Zhaoke Ophthalmology sees issued shares rise following option exercise

Zhaoke Ophthalmology Limited reported an increase of 15,000 ordinary shares in its issued share capital for the month ended November 30, 2025. This brings the total number of issued shares (excluding treasury shares) to 547,970,012. The movement stemmed from the exercise of share options under the Post-IPO Share Option Scheme, adopted on April 1, 2021, specifically from a grant made on December 15, 2022.

The exercise of these options generated total funds of HK$48,900 for the company during the month. Despite these changes, the company's authorized/registered share capital remained constant at 1,600,000,000,000 USD, with a corresponding authorized/registered share capital value of USD 400,000.

Outstanding share options under various schemes also saw adjustments. The number of outstanding options under the Pre-IPO Share Option Scheme remained at 26,575,516, while the Post-IPO Share Option Scheme (grant on December 15, 2022) had 5,185,500 options outstanding, reflecting the 15,000 options exercised. Other Post-IPO grants (July 2024 and September 2025) maintained 4,099,500 and 8,000,000 options outstanding, respectively.